Minervax Aps
Clinical trials sponsored by Minervax Aps, explained in plain language.
-
Could a vaccine shield newborns from a deadly bacterial infection?
⭐️ VACCINE ⭐️ CompletedThis study tests an experimental vaccine called GBS-NN/NN2 against Group B Streptococcus (GBS), a bacteria that can cause serious infections in newborns. The trial includes pregnant women both with and without HIV, giving two doses between 26 and 30 weeks of pregnancy. Researcher…
Phase: PHASE2 • Sponsor: Minervax ApS • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 16, 2026 00:00 UTC
-
New vaccine targets group b strep in seniors
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tested a new vaccine against Group B Streptococcus (GBS) in 90 healthy adults aged 55 to 75. Participants received three doses of the vaccine or a placebo, and researchers monitored safety and immune response for six months. The goal is to see if the vaccin…
Phase: PHASE1 • Sponsor: Minervax ApS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 13:27 UTC